ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

AN ASSESSMENT OF BREAST CANCER REOCCURRENCE RATE WITH RESPECT TO AGE, EDUCATIONAL STATUS, PARITY AND MARITAL STATUS

AUTHORS:

1Dr. Iram Abdul Razzaq, 2Dr. Sheeza Jabeen, 3Dr. Muhammad Mateen Shahid

ABSTRACT:

Objective: The objective of the research was to evaluate the periodical rate of a breast tumour. Material and Methods: The design of the research was cross-sectional, performed at the Department of Surgery, Sharif Medical Hospital Lahore from March 2017 to February 2018. The number of females selected by the researcher for the study was one hundred and ten having age in between thirty to sixty years along with conduction of revising radical mastectomy in entire patients. Researcher reevaluated the entire patients after the period of six months as a follow-up to find out periodical rate of a breast tumour. Results: The number of females selected by the researcher for the study was one hundred and ten having age between thirty to sixty years. Researcher diagnosis breast tumour periodicity in twenty-five (twenty-three percent) patients. The number of patients associated with age category of less than thirty years was eleven (ten percent) succeeded by thirteen (11.82%) patients of thirty to forty-year age category, forty-one (37.27%) patients to age category of forty-one to fifty years along with forty-five (40.91%) patients to age category of fifty-one to sixty years. The researcher recorded the periodicity of a breast tumour in two (18.18%), three (23.08%), ten (24.39%), and ten (22.22%) patients respectively and also recorded statistically important linkage of periodicity with age categorization along with P value = 0.9776. Conclusion: The finding of our research presented an increased rate of the periodicity of breast cancer after revising radical mastectomy and most patients are in between fifty to sixty years’ age of life. Keywords: Radiotherapy, Breast Carcinoma, Hormonal, Mastectomy, Unaltered.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.